The results of the gut and brain proteomics suggested that the IDO-AhR pathway was affected by BPs, while the IDO-AhR and TpH1-5-HT pathways played important roles following treatment with BPs combined with probiotics. The gene discussed is IDO1; the disease is Bartsocas-Papas syndrome 1.